Other stem cell markers of HCC easily resistant to sorafenib include CD44+ or CD44+CD133+ subpopulations, suggesting liver CSCs play a critical role in sorafenib resistance [11, 19]. Here, CD44 is linked to hepatocellular carcinoma.